← Evidence map

ReviewEndocrinology and metabolism (Seoul, Korea)2022

Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature.

Wei Lin Tay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35417954